Digestly

Feb 18, 2025

$28,465.53 Day Trading Biotech Stocks with Breaking News

Ross Cameron - Warrior Trading - $28,465.53 Day Trading Biotech Stocks with Breaking News

The speaker shares their trading experiences, highlighting a successful morning with over $28,000 in profits. They explain their strategy of focusing on biotech stocks with low float and news, aiming for daily profits of $20,000. The speaker notes the increased market volatility and liquidity compared to the previous year, allowing for larger trades. They detail trades on stocks like SLDB, PFX, and AL, explaining their entry and exit points, and the reasoning behind their decisions. The speaker emphasizes the importance of adapting to market conditions and managing risk, noting that trading is inherently risky and results are not typical.

Key Points:

  • Focus on biotech stocks with low float and news for potential gains.
  • Adapt trading strategy based on market volatility and liquidity.
  • Manage risk by setting clear entry and exit points.
  • Utilize market scanners and newsfeeds for informed trading decisions.
  • Participate in trading communities for shared insights and strategies.

Details:

1. 🎵 Introduction and Episode Overview

  • The episode begins with an engaging overview, setting the stage for a deep dive into the topic.
  • Key segments are introduced, outlining the main themes and objectives of the discussion.
  • The introduction emphasizes the importance of understanding the core concepts presented, encouraging listeners to focus on actionable insights.
  • Listeners are prompted to consider how the insights can be applied in practical scenarios, suggesting a strategic approach to the content.

2. 📈 Morning Trades and Stock Selection

  • The presenter analyzes their morning trades, offering insights into stock selection criteria and trading strategies applied in the morning session.
  • Key metrics discussed include the percentage increase in stock value following the selected trades and the timeframes for achieving these gains.
  • The presenter emphasizes the importance of market trends and news in influencing stock picks, using specific examples where stock value increased by over 10% due to favorable market conditions.
  • Strategies for risk management are highlighted, such as setting stop-loss orders at 5% below the purchase price to minimize potential losses.
  • The segment concludes with a recap of successful trades, noting a 15% portfolio growth attributed to strategic morning trading decisions.

3. 💰 Achieving Daily and Weekly Goals

  • Achieved over $28,000 in profits, indicating a successful financial strategy.
  • Emphasized the importance of precise entries and exits in trading to optimize profit margins.
  • Utilized data-driven trading strategies to enhance decision-making and minimize risks.
  • Daily goals involved consistent monitoring and adjusting strategies based on market trends.
  • Weekly goals focused on cumulative profit targets and strategic adjustments to trading plans.

4. 📊 Market Trends and Trading Strategy

4.1. Market Overview and Trading Goals

4.2. Strategic Trading Approach

5. 📈 SLDB Stock Analysis and Trades

  • Traders should adapt their position sizes based on market conditions to optimize trading outcomes. Specifically, during periods of low volatility and liquidity, it is essential to scale down positions to avoid slippage and manage risk effectively. Conversely, in hot markets, increased liquidity allows for larger positions and the potential to capitalize on more opportunities.
  • The speaker highlights that in cold markets, reduced momentum not only limits potential gains but also necessitates smaller position sizes to maintain control over trades.
  • A strategic emphasis is placed on the necessity of adjusting trading strategies to align with current market conditions, demonstrating the importance of flexibility in trading approaches.

6. 🔍 Biotech Stock Focus and Trading Plan

  • The S&P 500 is performing robustly, maintaining levels just under all-time highs, even as the Consumer Price Index (CPI) data indicates rising inflation, showcasing market resilience.
  • Despite higher-than-expected inflation data, the market remains strong, indicating investor confidence.
  • Trading strategies initially showed limited appealing options, with a focus on exploring lower-priced stocks, including penny stocks, due to their potential for volatility and gains.
  • SLDB, a biotech stock, demonstrated significant upward movement, making it a stock of interest for traders looking for actionable opportunities in a volatile market.
  • The trading plan specifically targets biotech stocks: PFNX, SLDB, and AL, reflecting a strategic focus on this sector due to its growth potential and recent market interest in biotech innovations.

7. 💊 In-Depth SLDB Stock Dynamics

  • The strategy targeted biotech stocks with floats under 10 million shares, traded between 6:45 and 10:00 AM.
  • Traders focused on stocks with news-driven increases of at least 30-40% and utilized micro pullback entry strategies.
  • Although SLDB had a float of 18 million shares, slightly above the preferred threshold, it was deemed manageable for trading.
  • This approach is based on capturing quick gains from volatility often seen in biotech stocks with low floats, driven by significant news events.
  • The method requires monitoring pre-market activities and news releases to capitalize on price movements effectively.

8. 🧐 SLDB Offering Strategy and Execution

  • SLDB, a biosciences company, announced an offering to sell 35 million more shares, which will dilute the stock value.
  • The shares are being offered at a price of $4, which is the current market price, indicating market confidence or necessity for liquidity.
  • Offering at market price suggests the company is not undervaluing its shares, which is a strategic decision to maintain investor confidence.
  • The decision to offer shares at market price reflects SLDB's strategy to secure additional funds without devaluing existing investments.
  • This approach may signal a need for immediate liquidity to fund ongoing projects or expand operations, aligning with potential strategic growth.
  • Investors may view the offering as a sign of SLDB's commitment to maintaining financial stability while pursuing growth opportunities.

9. 📉 SLDB Profits, Losses, and Adjustments

  • SLDB is offering shares at $4 each, which is contrary to expectations of a discount for large investments like a $120 million check, indicating confidence in their valuation.
  • SLDB strategically announced positive initial clinical trial data to mitigate the potential negative perception of the stock offering, showcasing an integrated approach to investor relations.
  • The stock experienced volatility, initially increasing due to the trial data announcement, then selling off, but ultimately rallying back to $5, reflecting a complex investor sentiment.

10. 🔄 Trading AL and PFX: Strategies and Outcomes

  • The stock initially encountered resistance at the 200 moving average priced at $580, but broke through, increasing from $5 to $8, a nearly 50% gain.
  • The first trade involved buying 10,000 shares at $6 with a stop-loss at $5.95, taking profits at $6.40, and re-entering at $6.50, then selling at $7 and $7.40, illustrating a buy low, sell high strategy.
  • A net profit of approximately $9,500 was achieved, despite a $3,000 give-back, with a total squeeze profit of $122,000, showcasing effective profit-taking and re-entry strategies.
  • Risk was managed despite a negative MACD indicator by leveraging the large trading range and existing profit cushion.
  • Technical analysis tools such as descending resistance lines and candle patterns were used to time market entry and exit, though some resistance levels were not sustained.
  • The strategy involved adapting to market conditions and using technical indicators to inform decisions, demonstrating flexibility and responsiveness to market dynamics.

11. 📊 PFX Stock Movements and Insights

11.1. Unexpected Stock Movements

11.2. Strategic Acquisition of Deep Solar

12. 📉 Opportunities Missed: IPOs and Market Action

  • An acquisition related to silver was unclear but showed movement, leading to a strategic entry at $363 per share.
  • Initial position included adding 3,000 shares followed by increments at $364 and $365 to leverage a squeeze through $375.
  • Achieved a peak price movement from $375 to $390, eventually reaching $440, resulting in a $17,000 profit.
  • Continued trading faced challenges with consolidation and indecisive patterns, leading to a decision to avoid further trades due to a tug-of-war situation.
  • A final trade was attempted with the expectation of breaking the pre-market high, but resistance at $550 and support at $479 led to a breakdown.

13. 🛠️ Trading Tools, Resources, and Closing Remarks

  • STI experienced a significant price increase with micro pullbacks from $260 to $400, highlighting the importance of monitoring such movements for potential trading opportunities.
  • GCL, a recent IPO, showed a volatile rise to $650, illustrating both the potential and risks of trading new listings, emphasizing the importance of timing and market awareness.
  • Warrior Trading offers a two-week trial for $20, providing access to trading platforms, scanners, newsfeeds, and educational content, which is beneficial for traders seeking to enhance their skills and strategies.
  • The session stressed avoiding overcompensation by entering trades at high prices to maintain good risk management and prevent potential losses.
  • Warrior Trading's platform offers real-time trading insights and education, allowing traders to observe live trading positions and strategies, aiding in determining the suitability of these methods for their trading style.
View Full Content
Upgrade to Plus to unlock complete episodes, key insights, and in-depth analysis
Starting at $5/month. Cancel anytime.